Ambrx Biopharma Inc. (AMAM)
Company Info
ISIN | US02290A1025 |
---|---|
CUSIP | 02290A102 |
Sector | Healthcare |
Industry | Biotechnology |
Trading Data
Previous Close | $1.80 |
---|---|
Year Range | $0.41 - $5.12 |
EMA (50) | $1.77 |
EMA (200) | $2.48 |
Average Volume | $4.63M |
Market Capitalization | $69.51M |
AMAMShare Price Chart
Loading data...
AMAMPerformance
The chart shows the growth of $10,000 invested in Ambrx Biopharma Inc. in Sep 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $1,056 for a total return of roughly -89.44%. All prices are adjusted for splits and dividends.
AMAMCompare to other instruments
AMAMReturns in periods
Period | Return | Benchmark |
---|---|---|
1M | -13.04% | 8.17% |
YTD | -20.70% | 7.73% |
6M | -23.40% | -0.37% |
1Y | -60.78% | -9.87% |
5Y | -74.89% | -0.44% |
10Y | -74.89% | -0.44% |
AMAMMonthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | -16.74% | |||||||||||
2022 | -40.65% | -34.55% | -9.54% | -49.85% | 363.27% |
AMAMDividend History
Ambrx Biopharma Inc. doesn't pay dividends
AMAMDrawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
AMAMWorst Drawdowns
The table below shows the maximum drawdowns of the Ambrx Biopharma Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Ambrx Biopharma Inc. is 98.18%, recorded on Dec 8, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-98.18% | Jul 14, 2021 | 356 | Dec 8, 2022 | — | — | — |
-6.45% | Jun 21, 2021 | 2 | Jun 22, 2021 | 3 | Jun 25, 2021 | 5 |
-4.08% | Jul 1, 2021 | 1 | Jul 1, 2021 | 2 | Jul 6, 2021 | 3 |
-2.47% | Jul 9, 2021 | 2 | Jul 12, 2021 | 1 | Jul 13, 2021 | 3 |
-2.27% | Jun 28, 2021 | 1 | Jun 28, 2021 | 1 | Jun 29, 2021 | 2 |
-0.15% | Jul 7, 2021 | 1 | Jul 7, 2021 | 1 | Jul 8, 2021 | 2 |
AMAMVolatility Chart
Current Ambrx Biopharma Inc. volatility is 96.41%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.